Syndecan 1 plays a novel role in enteral glutamine's gut-protective effects of the postischemic gut

Shock

Volumn 38, Issue 1, 2012, Pages 57-62

  Peng, Zhanglong ^a   Ban, Kechen ^a   Sen, Aritra ^a   Grill, Raymond ^a   Park, Pyong ^b   Costantini, Todd W ^c   Kozar, Rosemary ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

epithelial cells; gut ischemia reperfusion; Heparan sulfate; hypoxia reoxygenation; permeability

Indexed keywords

CASPASE 3; CASPASE 7; GLUTAMINE; MESSENGER RNA; MYELOPEROXIDASE; SYNDECAN 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; CELL GROWTH; CELL HYPOXIA; CELL MEMBRANE PERMEABILITY; CELL PROLIFERATION; CELL PROTECTION; CELL SURFACE; CONTROLLED STUDY; ENTERIC FEEDING; ENTERITIS; ENZYME ACTIVITY; HISTOPATHOLOGY; INTESTINE EPITHELIUM CELL; INTESTINE INJURY; INTESTINE ISCHEMIA; INTESTINE MUCOSA; INTESTINE MUCOSA PERMEABILITY; MOUSE; NONHUMAN; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SEROSA; SUPPLEMENTATION; WILD TYPE;

ANIMALS; CASPASES; CELL DIVISION; CELL HYPOXIA; CELLS, CULTURED; EPITHELIAL CELLS; GLUTAMINE; INTESTINAL DISEASES; INTESTINAL MUCOSA; INTESTINES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PERMEABILITY; RATS; REPERFUSION INJURY; SYNDECAN-1;

EID: 84862770201     PISSN: 10732322     EISSN: 15400514     Source Type: Journal    
DOI: 10.1097/SHK.0b013e31825a188a     Document Type: Article

References (30)

1. Pfeifer R, Tarkin IS, Rocos B, Pape HC: Patterns of mortality and causes of death in polytrauma patients-has anything changed? Injury 40(9):907-911, 2009.
2. Moore FA, Feliciano DV, Andrassy RJ, McArdle AH, Booth FV, Morgenstein-Wagner TB, Kellum JM Jr, Welling RE, Moore EE: Early enteral feeding, compared with parenteral, reduces postoperative septic complicationsVthe results of a meta-analysis. Ann Surg 216:172-183, 1992.
3. Santora R, Kozar RA: Molecular mechanisms of pharmaconutrients [published online ahead of print July 17, 2009]. J Surg Res 15;161(2):288-294, 2010.
4. McQuigan M, Kozar RA, Moore FA: Enteral glutamine during active shock resuscitation is safe and enhances tolerance. JPEN 32(1):28-35, 2008.
5. Rupani B, Caputo FJ, Watkins AC, Vega D, Magnotti LJ, Lu Q, Xu da Z, Deitch EA: Relationship between disruption of the unstirred mucus layer and intestinal restitution in loss of gut barrier function after trauma hemorrhagic shock. Surgery 2007;141(4):481-489, 2007. (Pubitemid 46441309)
6. Kozar RA, Schultz SG, Hassoun HT, DeSoignie R, Weisbrodt NW, Haber MH, Moore FA: The type of sodium-coupled solute modulates small bowel mucosal injury, transport function and ATP after Ischemia/reperfusion injury in rats. Gastroenterology 123(3):810-816, 2002. (Pubitemid 34977087)
7. Kozar RA, Schultz SG, Bick RJ, Poindexter BJ, DeSoignie R, Moore FA: Enteral glutamine but not alanine maintains small bowel barrier function after ischemia/reperfusion injury in rats. Shock 21(5):433-437, 2004.
8. Bode L, Salvestrini C, Park PW, Li JP, Esko JD, Yamaguchi Y, Murch S, Freeze HH: Heparan sulfate and syndecan-1 are essential in maintaining murine and human intestinal epithelial barrier function. J Clin Invest 118:229-238, 2008.
9. Day R, Forbes A. Heparin, cell adhesion, and pathogenesis of inflammatory bowel disease. Lancet 354:62-65, 1999. (Pubitemid 29304311)
10. Ban K, Kozar RA: Glutamine protects against apoptosis via downregulation of Sp3 in intestinal epithelial cells. Am J Physiol Liver Physiol 209:G1344-G1353, 2010.
11. Ban K, Santora R, Kozar RA. Enteral arginine modulates inhibition of AP-1/c-Jun by SP600125 in the postischemic gut [published online ahead of print October 29, 2010]. Mol Cell Biochem 347:191-199, 2011.
12. Kozar RA, Peng Z, Zhang R, Holcomb JB, Pati S, Park P, Ko TC, Paredes A: Plasma restoration of endothelial glycocalyx in a rodent model of hemorrhagic shock. Anesth Analg 112:1289-1295, 2011.
13. Park PW, Pier GB, Hinkes MT, Bernfield M: Exploitation of syndecan-1 shedding by Pseudomonas aeruginosa enhances virulence. Nature 411:98-102, 2001. (Pubitemid 32428197)
14. Sato N, Moore FA, Smith MA, Zou L, Olufemi-Moore S, Schultz SG, Kozar RA: Differential induction of PPAR{gamma} by luminal glutamine and iNOS by luminal arginine in the rodent post ischemic small bowel [published online ahead of print October 27, 2005]. Am J Physiol Gastrointest Liver Physiol 290(4):G616-G623, 2006.
15. Hassoun H, Zou L, Moore FA, Kozar RA, Weisbrodt NW, Kone B: Melanocytestimulating hormone protects against mesenteric ischemia-reperfusion injury. Am J Physiol Cell Physiol 282:C1059-C1068, 2002.
16. Wattanasirichaigoon S, Menconi MJ, Delude RL, Fink MP: Lisofylline ameliorates intestinal mucosal barrier dysfunction caused by ischemia and ischemia/reperfusion. Shock 11(4):269-275, 1999.
17. Tawadrous ZS, Delude RL, Fink MP: Resuscitation from hemorrhagic shock with Ringer's ethyl pyruvate solution improves survival and ameliorates intestinal mucosal hyperpermeability in rats. Shock 17(6):473-477, 2002.
18. Deitch EA, Shi HP, Lu Q, Feketeova E, Xu DZ: Serine proteases are involved in the pathogenesis of trauma-hemorrhagic shock-induced gut and lung injury. Shock 19:452-456, 2003. (Pubitemid 44305172)
19. Costantini TW, Eliceiri E, Peterson CY, Loomis WH, Putnam JG, Baird A, Wolf P, Bansal V, Coimbra R: Quantitative assessment of intestinal injury using a novel in vivo, near-infrared imaging technique. Mol Imaging 9:30-39, 2010.
20. Hayashida K, Johnston DR, Goldberger O, Park PW: Syndecan-1 expression in epithelial cells is induced by transforming growth factor beta through a PKAdependent pathway. J Biol Chem 281:24365-24374, 2006. (Pubitemid 44274208)
21. Yeaman C, Rapraeger AC: Post-transcriptional regulation of syndecan-1 expression by cAMP in peritoneal macrophages. J Cell Biol 122:941-950, 1993. (Pubitemid 23241103)
22. Baker AH, Edwards DR, Murphy G: Metalloproteinase inhibitors: biological actions and therapeutic opportunities. J. Cell Sci 115:3719-3727, 2002. (Pubitemid 35203598)
23. Edwards DR, Handsley MM, Pennington CJ: The ADAM metalloproteinases. Mol Aspects Med 29:258-289, 2008.
24. Pruessmeyer J, Martin C, Hess FM, Schwarz N, Schmidt S, Kogel T, Hoettecke N, Schmidt B, Sechi A, Uhlig S, et al.: A disintegrin and metalloproteinase 17 (ADAM17) mediates inflammation-induced shedding of syndecan-1 and-4 by lung epithelial cells. J Biol Chem 285:555-564, 2010.
25. Hayashida K, Parks WC, Park PW: Syndecan-1 shedding facilitates the resolution of neutrophilic inflammation by removing sequestered CXC chemokines. Blood 114:3033-3043, 2009.
26. Kliment CR, Englert JM, Gochuico BR, Yu G, Kaminski N, Rosas I, Oury TD: Oxidative stress alters syndecan-1 distribution in lungs with pulmonary fibrosis. J Biol Chem 284:3537-3545, 2009.
27. Robinson EK, Kelly DP, Mercer DW, Kozar RA: Differential effects of luminal arginine and glutamine on metalloproteinase production in the postischemic gut. JPEN 32:433-438, 2008. (Pubitemid 351875944)
28. Endo K, Takino T, Miyamori H, Kinsen H, Yoshizaki T, Furukawa M, Sato H: Cleavage of syndecan-1 by membrane type matrix metalloproteinase-1 stimulates cell migration. J Biol Chem 278:40764-40770, 2003. (Pubitemid 37280893)
29. Celie JW, Katta KK, Adepu S, Melenhorst WB, Reijmers RM, Slot EM, Beelen RH, Spaargaren M, Ploeg RJ, Navis G, et al.: Tubular epithelial syndecan-1 maintains renal function in murine ischemia/reperfusion and human transplantation [published online ahead of print]. Kidney Int 81(7):651-661, 2012.
30. Lundin M, Nordling S, Lundin J, Isola J, Wiksten JP, Haglund C: Epithelial syndecan-1 expression is associated with stage and grade in colorectal cancer. Oncology 68(4-6):306-313, 2005. (Pubitemid 41160958)